Patent ID: 11873343
Assignee: AMGEN INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 25:
26. The container of claim 1, comprising an aqueous pharmaceutical formulation comprising (i) about 100 mg/mL to about 140 mg/mL of an anti-receptor activator of nuclear factor kappa-B ligand (anti-RANKL) antibody and (ii) about 5 mM to about 100 mM phenylalanine or tryptophan, (iii) about 2.0 (w/w) % to about 5.0 (w/w) % tonicity modifier, and (iv) about 0.004 (w/v) % surfactant and less than 0.15 (w/v) % surfactant, wherein the aqueous pharmaceutical formulation has a pH in a range of about 5.0 to about 5.2.